Catalyst Wire Dossier Catalyst Wire Dossier

GLH8NDE

· GL Pharm Tech Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLH8NDE, covering 2021-01-06 to 2021-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease [Phase 2]

See pricing